James G. Martin
Professor
Respiratory Division
McGill University
Canada
Biography
Meakins-Christie Laboratories
Research Interest
Dr Martin's primary interest is the pathophysiology of asthma. Dr Martin is Chair, Department of Medicine of McGill University and Physicianâ€in†Chief of the McGill University Health Centre.
Publications
-
Therapeutic drug monitoring in the treatment of active tuberculosis. Babalik A, Babalik A, Mannix S, Francis D, Menzies D.
-
Three months of rifapentine and isoniazid for latent tuberculosis infection. Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team.
-
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical
